Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free anesthesia with dexmedetomidine in total hip arthroplasty
2021-003703-18Phase 3Completed
- Sponsor
- CMC Ambroise Paré
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by CMC Ambroise Paré. Primary endpoint: Postoperative cumulated oxycodone dose in oral morphine equivalent. Started Jul 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2021-003703-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003703-18.